Walmart fires US antitrust broadside at generic drug industry’s ‘fair-share’ scheme
Walmart filed a massive antitrust complaint in Pennsylvania federal court today accusing dozens of generic drug manufacturers of a nationwide, anticompetitive conspiracy centered around a “fair-share” agreement that fueled price increases...To view the full article, register now.
Already a subscriber? Click here to view full article